Date:1/24/2012

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 U.S.2,850 

 2,861 

(0.4)

 

(0.4)

 

-

 11,371 11,412 

(0.4)

 

(0.4)

 

-International3,643 

 3,463 

5.2

 

4.6

 

0.6

 14,408 13,189 

9.2

 

3.4

 

5.8 6,493 

 6,324 

2.7

 

2.4

 

0.3

 25,779 24,601 

4.8

 

1.7

 

3.1 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 U.S.6,985 

 7,229 

(3.4)

 

(3.4)

 

-

 28,908 29,450 

(1.8)

 

(1.8)

 

-International9,270 

 8,415 

10.2

 

10.4

 

(0.2)

 36,122 32,137 

12.4

 

7.0

 

5.4Worldwide$
,255 

 15,644 

3.9

%

4.0

 

(0.1)

 $
5,030 61,587 

5.6

%

2.8

 

2.8 

 

'/>"/>

SOURCE Johnson & Johnson Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33
Related medicine technology :

1. Johnson & Johnson to Provide Webcast Presentation of Tapentadol Phase 3 Clinical Data Presented at American Pain Societys Annual Meeting
2. Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Announces FDA Filings for Paliperidone Palmitate and INVEGA(R)
3. Simbionix and Johnson & Johnson LLC Announce Distribution Agreement at Russia and the CIS Countries
4. Johnson & Johnson Announces Support for Kohl-Grassley Physician Payments Sunshine Act of 2009
5. Boston Scientific and Johnson & Johnson Announce Settlement of Patent Disputes
6. Palomar to Commercialize FDA Cleared Over-The-Counter Home Use Wrinkle Treatment Laser Device Without Johnson & Johnson
7. U.S. Files Suit Against Johnson & Johnson For Paying Kickbacks to Nations Largest Nursing Home Pharmacy
8. EF Johnson Technologies Announces Third Quarter Results
9. Emerging Agents from Theravance/Astellas, Johnson & Johnson/Basilea and Forest/Astrazeneca/Takeda Will Drive Modest Growth in the MRSA Drug Market Through 2018
10. Johnson & Johnson to Participate in the 30th Annual Cowen and Company Health Care Conference
11. Two Johnson & Johnson Subsidiaries to Pay Over $81 Million to Resolve Allegations of Off-Label Promotion of Topamax